Corrigendum: Case report: A sustained survival benefit of third-line immunotherapy for refractory thymic carcinoma

Affiliations

Mi Meng: Department of Thoracic Oncology, The second Affiliated Hospital of Zunyi Medical University, Zunyi, China
Bo Yu: Department of Urology, The second Affiliated Hospital of Zunyi Medical University, Zunyi, China
Jie Luo: Department of Radiation Oncology, Guiqian International General Hospital, Guiyang, China
Yuju Bai: Department of Thoracic Oncology, The second Affiliated Hospital of Zunyi Medical University, Zunyi, China
Lin Li: Department of Thoracic Oncology, The second Affiliated Hospital of Zunyi Medical University, Zunyi, China
Shicheng Chen: Department of Urology, The second Affiliated Hospital of Zunyi Medical University, Zunyi, China
Sisi He: Department of Thoracic Oncology, The second Affiliated Hospital of Zunyi Medical University, Zunyi, China
Hu Ma: Department of Thoracic Oncology, The second Affiliated Hospital of Zunyi Medical University, Zunyi, China

Abstract

No abstracts available.

ISSN: 2234-943X (Online)
Publisher: Frontiers Media S.A.
Country of publisher: Switzerland
LCC subjects: Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Website: https://www.frontiersin.org/journals/oncology/